James F. Cummings - 27 Sep 2021 Form 3 Insider Report for Vaxart, Inc. (VXRT)

Role
Chief Medical Officer
Signature
/s/ Margaret Echerd, Attorney-in-Fact for James Cummings
Issuer symbol
VXRT
Transactions as of
27 Sep 2021
Net transactions value
$0
Form type
3
Filing time
07 Oct 2021, 17:19:20 UTC
Next filing
30 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VXRT Stock Option (right to buy) 27 Sep 2021 Common stock 300,000 $8.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on August 16, 2022, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on August 16, 2025.